- Home
- MKZR vs IRIX Comparison
MKZR vs IRIX Comparison
Compare MKZR & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MKZR
- IRIX
- Stock Information
- Founded
- MKZR 2012
- IRIX 1989
- Country
- MKZR United States
- IRIX United States
- Employees
- MKZR N/A
- IRIX N/A
- Industry
- MKZR
- IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- MKZR
- IRIX Health Care
- Exchange
- MKZR Nasdaq
- IRIX Nasdaq
- Market Cap
- MKZR 19.1M
- IRIX 16.5M
- IPO Year
- MKZR N/A
- IRIX 1996
- Fundamental
- Price
- MKZR $1.11
- IRIX $1.00
- Analyst Decision
- MKZR
- IRIX Hold
- Analyst Count
- MKZR 0
- IRIX 1
- Target Price
- MKZR N/A
- IRIX $2.00
- AVG Volume (30 Days)
- MKZR 33.9K
- IRIX 77.4K
- Earning Date
- MKZR 01-01-0001
- IRIX 05-13-2025
- Dividend Yield
- MKZR 17.54%
- IRIX N/A
- EPS Growth
- MKZR N/A
- IRIX N/A
- EPS
- MKZR N/A
- IRIX N/A
- Revenue
- MKZR $23,087,751.00
- IRIX $48,669,000.00
- Revenue This Year
- MKZR N/A
- IRIX $9.61
- Revenue Next Year
- MKZR N/A
- IRIX N/A
- P/E Ratio
- MKZR N/A
- IRIX N/A
- Revenue Growth
- MKZR 57.39
- IRIX N/A
- 52 Week Low
- MKZR $1.05
- IRIX $0.78
- 52 Week High
- MKZR $5.50
- IRIX $3.25
- Technical
- Relative Strength Index (RSI)
- MKZR N/A
- IRIX 39.26
- Support Level
- MKZR N/A
- IRIX $1.14
- Resistance Level
- MKZR N/A
- IRIX $1.19
- Average True Range (ATR)
- MKZR 0.00
- IRIX 0.07
- MACD
- MKZR 0.00
- IRIX -0.01
- Stochastic Oscillator
- MKZR 0.00
- IRIX 4.90
About MKZR MacKenzie Realty Capital Inc.
Mackenzie Realty Capital Inc is a company which is a Real estate investment trust (REIT). The company has one reportable segment, income-producing real estate properties which consists of activities related to investing in real estate.
About IRIX IRIDEX Corporation
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.